Language

CAS No.2118959-55-8 | Ephos

Name: Ephos CAS No.2118959-55-8 MF: C36H55OP MW: 534.8 Purity:97% Package: 5g,25g,100g,500g,1kg,25kg Worldwide Delivery

Categories：

Analytical Chemicals

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

Introduction and application of CAS No.2118959-55-8 | Ephos

Ephos is a synthetic molecule that is used as a control agent in the Suzuki coupling reaction. It is an amide with two functional groups and nitrogen atoms. Ephos has been shown to have anti-cancer properties, as well as being an inhibitor of cdk4/6. This makes it can be used for the treatment of autoimmune diseases, such as arthritis and psoriasis. Ephos also inhibits the growth of tumor cells in mice by preventing the activation of CDK4/CDK6 complexes.

Synonyms:

Phosphine, dicyclohexyl[3-(1-methylethoxy)-2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]-

Specification of CAS No.2118959-55-8 | Ephos

ITEMS	SPECIFICATION
CAS No.	2118959-55-8
MF	C36H55OP
MW	534.8
Melting point	161-162 °C
Boiling point	612.7±55.0 °C(Predicted)

Package of CAS No.2118959-55-8 | Ephos

Package:100g; 500g; 1kg; 25kg;bulk package

Transportation: by courier/ by air/ by sea

Related Articles of CAS No.2118959-55-8 | Ephos

Combined perioperative lapatinib and trastuzumab in early HER2-positive breast cancer identifies early responders: randomized UK EPHOS-B trial long-term results

N Bundred, N Porta, AM Brunt, A Cramer, A Hanby… - Clinical Cancer …, 2022 - AACR

Purpose: EPHOS-B aimed to determine whether perioperative anti-HER2 therapy inhibited
proliferation and/or increased apoptosis in HER2-positive breast cancer. Patients and …

Key words: